The estimated $1 billion media account for GlaxoSmithKline Consumer Healthcare is in play again.

Allergan and Ironwood want to help people talk about their guts with their doctors—specifically, their possible IBS symptoms.

Roche’s Tecentriq-Avastin-chemo combo may have just scored a quicker trip into the first-line lung arena, where a Merck rivalry awaits.

Merck, a recent victim of investor "conspiracy theories," last week changed up its communications game to answer some immuno-oncology questions.

If you've been following pharma's “smart inhaler” deals, you might think the industry's up to speed on sensor tech—but you'd be wrong.

Ironwood’s first campaign for gout treatment Duzallo features sausage and shrimp as visual reminders that while patients many not always be perfect food choice…

Pharma companies want to know what all the hype's about when it comes to artificial intelligence.

If the competition between Novartis and Gilead in relapsed large B-cell lymphoma comes down to price, it will be a close race.